Molecular Neurodegeneration,
Journal Year:
2021,
Volume and Issue:
16(1)
Published: Sept. 30, 2021
N6-methyladenosine
(m6A)
modification
of
RNA
influences
fundamental
aspects
metabolism
and
m6A
dysregulation
is
implicated
in
various
human
diseases.
In
this
study,
we
explored
the
potential
role
pathogenesis
Alzheimer
disease
(AD).We
investigated
expression
regulators
brain
tissues
AD
patients
determined
impact
underlying
mechanism
manipulated
levels
on
AD-related
deficits
both
vitro
vivo.We
found
decreased
neuronal
along
with
significantly
reduced
methyltransferase
like
3
(METTL3)
brains.
Interestingly,
hippocampus
caused
by
METTL3
knockdown
led
to
significant
memory
deficits,
accompanied
extensive
synaptic
loss
death
multiple
cellular
alterations
including
oxidative
stress
aberrant
cell
cycle
events
vivo.
Inhibition
or
alleviated
shMettl3-induced
apoptotic
activation
damage
primary
neurons.
Restored
inhibiting
its
demethylation
rescued
abnormal
events,
induced
knockdown.
Soluble
Aβ
oligomers
exacerbated
while
overexpression
Aβ-induced
PSD95
vitro.
Importantly,
cognitive
impairment
vivo.Collectively,
these
data
suggested
that
reduction-mediated
likely
contributes
neurodegeneration
which
may
be
a
therapeutic
target
for
AD.
Cell Reports,
Journal Year:
2019,
Volume and Issue:
26(13), P. 3762 - 3771.e5
Published: March 1, 2019
Chemical
modifications
of
RNA
provide
an
additional,
epitranscriptomic,
level
control
over
cellular
functions.
N-6-methylated
adenosines
(m6As)
are
found
in
several
types
RNA,
and
their
amounts
regulated
by
methyltransferases
demethylases.
One
the
most
important
enzymes
catalyzing
generation
m6A
on
mRNA
is
trimer
N-6-methyltransferase
METTL3-14-WTAP
complex.
Its
activity
has
been
linked
to
such
critical
biological
processes
as
cell
differentiation,
proliferation,
death.We
used
silico-based
discovery
identify
small-molecule
ligands
that
bind
determined
experimentally
binding
affinity
kinetics,
well
effect
enzymatic
function.
We
show
these
serve
activators
Cell Death and Disease,
Journal Year:
2020,
Volume and Issue:
11(11)
Published: Nov. 8, 2020
Abstract
Similar
to
DNA
epigenetic
modifications,
multiple
reversible
chemical
modifications
on
RNAs
have
been
uncovered
in
a
new
layer
of
modification.
N6-methyladenosine
(m
6
A),
modification
that
occurs
~30%
transcripts,
is
dynamically
regulated
by
writer
complex
(methylase)
and
eraser
(RNA
demethylase)
proteins,
recognized
reader
A-binding)
proteins.
The
effects
m
A
are
reflected
the
functional
modulation
mRNA
splicing,
export,
localization,
translation,
stability
regulating
RNA
structure
interactions
between
RNA-binding
This
involved
variety
physiological
behaviors,
including
neurodevelopment,
immunoregulation,
cellular
differentiation.
disruption
modulations
impairs
gene
expression
function
ultimately
leads
diseases
such
as
cancer,
psychiatric
disorders,
metabolic
disease.
review
focuses
mechanisms
functions
behaviors
diseases.
Annual Review of Vision Science,
Journal Year:
2020,
Volume and Issue:
6(1), P. 195 - 213
Published: Sept. 15, 2020
The
damage
or
loss
of
retinal
ganglion
cells
(RGCs)
and
their
axons
accounts
for
the
visual
functional
defects
observed
after
traumatic
injury,
in
degenerative
diseases
such
as
glaucoma,
compressive
optic
neuropathies
from
glioma.
By
using
nerve
crush
injury
models,
recent
studies
have
revealed
cellular
molecular
logic
behind
regenerative
failure
injured
RGC
adult
mammals
suggested
several
strategies
with
translational
potential.
This
review
summarizes
these
findings
discusses
challenges
developing
clinically
applicable
neural
repair
strategies.
Molecular Neurodegeneration,
Journal Year:
2021,
Volume and Issue:
16(1)
Published: Sept. 30, 2021
N6-methyladenosine
(m6A)
modification
of
RNA
influences
fundamental
aspects
metabolism
and
m6A
dysregulation
is
implicated
in
various
human
diseases.
In
this
study,
we
explored
the
potential
role
pathogenesis
Alzheimer
disease
(AD).We
investigated
expression
regulators
brain
tissues
AD
patients
determined
impact
underlying
mechanism
manipulated
levels
on
AD-related
deficits
both
vitro
vivo.We
found
decreased
neuronal
along
with
significantly
reduced
methyltransferase
like
3
(METTL3)
brains.
Interestingly,
hippocampus
caused
by
METTL3
knockdown
led
to
significant
memory
deficits,
accompanied
extensive
synaptic
loss
death
multiple
cellular
alterations
including
oxidative
stress
aberrant
cell
cycle
events
vivo.
Inhibition
or
alleviated
shMettl3-induced
apoptotic
activation
damage
primary
neurons.
Restored
inhibiting
its
demethylation
rescued
abnormal
events,
induced
knockdown.
Soluble
Aβ
oligomers
exacerbated
while
overexpression
Aβ-induced
PSD95
vitro.
Importantly,
cognitive
impairment
vivo.Collectively,
these
data
suggested
that
reduction-mediated
likely
contributes
neurodegeneration
which
may
be
a
therapeutic
target
for
AD.